Tecentriq is approved for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has worsened during or following platinum-containing chemotherapy, or within 12 months of receiving platinum-containing chemotherapy, either before (neoadjuvant) or after (adjuvant) surgical treatment.5/18 才批的，但是要化疗无效的情况用的，不是一线用药

回复 [url=http://forums.huaren.us/showtopic.aspx?topicid=2018475&postid=71770450#71770450]2楼玲珑二宝的帖子[/url] 非常感谢mm，我会转告家人。